Mineralys Therapeutics, Inc.

NASDAQ MLYS Stock
Yield per half year: +139.92%
Dividend yield: 0%
Sector: Healthcare

Fair price Mineralys Therapeutics, Inc.

Current price
37.14 $
Average price
52.47 $ +41.28%
Price based on EPS
52.47 $ +41.28%
10/10

Price based on EPS

Price = Price * (100 - CAGR EPS * Excess Key Rate) / 100
Key Rate = Key rate
Fair price = 52.47 $
Current price = 37.14 $ (difference = +41.28%)


Data

Discounted Cash Flow (Based EBITDA)

Price = (Terminal Value + Company Value) / Count shares
Price - Fair price
Terminal Value β€” cost in the post-forecast period
Company Value β€” cost during the forecast period
Count shares - Number of shares
Terminal Value = Discount Ebitda(5) * (1 + Ebitda Yield) / (WACC - Ebitda Yield)
Company Value = βˆ‘ (Future Ebitda / (1 + WACC) ^ 5)
WACC - weighted average cost of capital (taking into account country risks, inflation, taxes, etc.)
Fair price = -503.3 $
Current price = 37.14 $ (difference = -1 455.15%)


Data

Discounted Cash Flow (Based FCF)

Price = (Terminal Value + Company Value) / Count shares
Price - Fair price
Terminal Value β€” cost in the post-forecast period
Company Value β€” cost during the forecast period
Count shares - Number of shares
Terminal Value = Discount FCF(5) * (1 + FCF Yield) / (WACC - FCF Yield) ^ 5
Company Value = βˆ‘ (FCF / (1 + WACC) ^ 5)
WACC - weighted average cost of capital (taking into account country risks, inflation, taxes, etc.)
Fair price = -480.3 $
Current price = 37.14 $ (difference = -1 393.2%)


Data

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription

Subscribe